Cargando…

NRF-1 directly regulates TFE3 and promotes the proliferation of renal cancer cells

The role of transcription factor binding to IGHM enhancer 3 (TFE3) in renal cell carcinoma (RCC) is not well understood. Nuclear respiratory factor 1 (NRF-1) may be the positive upstream regulatory gene of TFE3. The aim of the present study was to determine whether NRF-1 could directly regulate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuang, Wenyuan, Dong, Xiang, Wang, Bo, Liu, Ning, Guo, Hongqian, Zhang, Chunni, Gan, Weidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323008/ https://www.ncbi.nlm.nih.gov/pubmed/34345304 http://dx.doi.org/10.3892/ol.2021.12940

Ejemplares similares

The suitability of NONO-TFE3 dual-fusion FISH assay as a diagnostic tool for NONO-TFE3 renal cell carcinoma
por: Liu, Ning, et al.
Publicado: (2020)

Gender difference analysis of Xp11.2 translocation renal cell carcinomas’s attack rate: a meta-analysis and systematic review
por: Zhuang, Wenyuan, et al.
Publicado: (2020)

Clinicopathological features and prognosis of TFE3-positive renal cell carcinoma
por: Dong, Xiang, et al.
Publicado: (2022)

PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue
por: Xiong, Lei, et al.
Publicado: (2017)

TFE3 fusions escape from controlling of mTOR signaling pathway and accumulate in the nucleus promoting genes expression in Xp11.2 translocation renal cell carcinomas
por: Yin, Xiaoqin, et al.
Publicado: (2019)

Postoperative recurrence of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion
por: Wang, Zhen, et al.
Publicado: (2017)

Newly Designed Break-Apart and ASPL-TFE3 Dual-Fusion FISH Assay Are Useful in Diagnosing Xp11.2 Translocation Renal Cell Carcinoma and ASPL-TFE3 Renal Cell Carcinoma: A STARD-Compliant Article
por: Chen, Xiancheng, et al.
Publicado: (2015)

A safe and effective treatment combination of neoadjuvant therapy and surgical resection for metastatic TFE3-rearranged renal cell carcinoma:a case report
por: Yang, Haiyang, et al.
Publicado: (2023)

Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis
por: Liu, Ning, et al.
Publicado: (2016)

Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients
por: Agizamhan, Sezim, et al.
Publicado: (2018)

Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11.2 translocation renal cell carcinoma
por: Liu, Ning, et al.
Publicado: (2022)

Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies
por: Cheng, Xiangming, et al.
Publicado: (2016)

Dynamic Contrast-Enhanced CT Characterization of Xp11.2 Translocation/TFE3 Gene Fusions versus Papillary Renal Cell Carcinomas
por: He, Jian, et al.
Publicado: (2015)

TFE3 regulates renal adenocarcinoma cell proliferation via activation of the mTOR pathway
por: Fang, Yuan, et al.
Publicado: (2017)

The KEAP1–NRF2 pathway regulates TFEB/TFE3-dependent lysosomal biogenesis
por: Ong, Athena Jessica S., et al.
Publicado: (2023)

MiT/TFE Family Renal Cell Carcinoma
por: Tang, Jinglong, et al.
Publicado: (2023)

Emerging roles and regulation of MiT/TFE transcriptional factors
por: Yang, Min, et al.
Publicado: (2018)

A Rare Partner of TFE3 in the Xp11 Translocation Renal Cell Carcinoma: Clinicopathological Analyses and Detection of MED15-TFE3 Fusion
por: Ye, Hong, et al.
Publicado: (2019)

Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N(6)-methyladenosine of PARP1 mRNA and downregulating PTEN
por: Yang, Lei, et al.
Publicado: (2021)

TRIM28 represses renal cell carcinoma cell proliferation by inhibiting TFE3/KDM6A-regulated autophagy
por: Song, Tanjing, et al.
Publicado: (2023)

Emerging roles of TFE3 in metabolic regulation
por: Li, Xingyu, et al.
Publicado: (2023)

Correction to: Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N(6)-methyladenosine of PARP1 mRNA and downregulating PTEN
por: Yang, Lei, et al.
Publicado: (2021)

Long Non-Coding RNA LINC02747 Promotes the Proliferation of Clear Cell Renal Cell Carcinoma by Inhibiting miR-608 and Activating TFE3
por: Ju, Xiang, et al.
Publicado: (2020)

Characteristics of peritumoral pseudocapsule in small renal cell carcinoma and its influencing factors
por: Dong, Xiang, et al.
Publicado: (2022)

NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma
por: Pei, Jianming, et al.
Publicado: (2019)

Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma
por: Sun, Guangxi, et al.
Publicado: (2021)

TFE3 gene rearrangement and protein expression contribute to a poor prognosis of renal cell carcinoma
por: Lin, Junyi, et al.
Publicado: (2023)

LncRNA like NMRK2 mRNA functions as a key molecular scaffold to enhance mitochondrial respiration of NONO-TFE3 rearranged renal cell carcinoma in an NAD(+) kinase-independent manner
por: Chen, Yi, et al.
Publicado: (2023)

NUPR1 promotes the proliferation and metastasis of oral squamous cell carcinoma cells by activating TFE3-dependent autophagy
por: Fan, Tengfei, et al.
Publicado: (2022)

Malignant renal epithelioid angiomyolipoma with TFE3 gene amplification mimicking renal carcinoma
por: Wang, Haili, et al.
Publicado: (2018)

Correction to: NUPR1 promotes the proliferation and metastasis of oral squamous cell carcinoma cells by activating TFE3-dependent autophagy
por: Fan, Tengfei, et al.
Publicado: (2022)

CARM1 promotes gastric cancer progression by regulating TFE3 mediated autophagy enhancement through the cytoplasmic AMPK-mTOR and nuclear AMPK-CARM1-TFE3 signaling pathways
por: Yang, Suzhen, et al.
Publicado: (2022)

Sunitinib treatment promotes metastasis of drug-resistant renal cell carcinoma via TFE3 signaling pathway
por: Li, Luchao, et al.
Publicado: (2021)

TFE3-rearranged renal cell carcinoma with osseous metaplasia and indolent behaviour
por: Aldera, Alessandro Pietro, et al.
Publicado: (2022)

Estrogen associates with female predominance in Xp11.2 translocation renal cell carcinoma
por: Lu, Yanwen, et al.
Publicado: (2023)

Direct binding of TFEα opens DNA binding cleft of RNA polymerase
por: Jun, Sung-Hoon, et al.
Publicado: (2020)

TFE3 regulates whole‐body energy metabolism in cooperation with TFEB
por: Pastore, Nunzia, et al.
Publicado: (2017)

Translation Inhibitors Activate Autophagy Master Regulators TFEB and TFE3
por: Dang, Thao Thi, et al.
Publicado: (2021)

Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinoma
por: Guo, Wei, et al.
Publicado: (2023)

Molecular Heterogeneity of Xp11.2 Translocation Renal Cell Carcinoma: The Correlation Between Split Signal Pattern in FISH and Prognosis
por: Zhu, Yiqi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r6onvue8etvslabga5epl1qg1u